A novel tool has added some clarity to the role of granulins in dementia, and highlighted them as a potential treatment target.
The California Institute for Regenerative Medicine (CIRM) announces that it is investing $15.9 million in a therapy to tackle ALS.
Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.
This article discusses two potential neural networks, the serotonergic system and the OTergic system, that could prove to be particularly useful targets for endocrine therapy.
This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.